All news (page 22)

• 

  26 February 2026

  Veolia Secures £1bn UK Waste Management Contracts for 2025

  11 new contracts with UK local authorities boost Veolia's municipal services by 35%, supporting decarbonisation and resource preservation.
• 

  26 February 2026

  Eni Reports Strong 2025 Financial and Strategic Progress

  Strong Q4 results with 35% net income growth. Major projects launched, production up 7%. LNG expansion, biofuels growth, and strategic partnerships enhance resilience and shareholder returns.
• 

  26 February 2026

  Clariant Achieves Third Year of EBITDA Margin Growth

  Q4 2025 sales rose 1% in local currencies. FY 2025 EBITDA margin up 180 basis points to 17.8%. Performance programs saved CHF 50M. 2026 sales expected flat; EBITDA margin around 18%.
• 

  26 February 2026

  Covestro Meets 2025 Guidance Amid Challenges

  Sales and EBITDA fell in 2025. Strategic moves and partnerships aim to boost growth. 2026 outlook: stable EBITDA, improved cash flow, and reduced emissions.
• 

  26 February 2026

  Technip Energies 2025 Financial Results

  Strong 2025 results with revenue and EBITDA growth, dividend increase, share buyback, and strategic acquisition. Positive outlook for 2026 with robust backlog and sustainability focus.
• 

  26 February 2026

  2025 Results: Arkema Performance Summary

  Strong cash flow and EBITDA, sales growth in key markets, successful capacity expansions, and sustainability progress. Dividend stable; 2026 targets slight EBITDA growth amid weak demand.

• 

  26 February 2026

  EEW Advances Flue Gas Cleaning Modernization in Helmstedt

  EEW invests in flue gas cleaning to meet strict emissions, enhance environmental performance, and ensure long-term site viability during ongoing operations in Helmstedt.
• 

  26 February 2026

  RWE Expands Italy's Wind and Solar Capacity to 235 MW

  RWE doubles its renewable projects in Italy, adding 123 MW in 2026. New wind and solar projects will power 190,000 homes, with more developments planned.
• 

  25 February 2026

  ViiV Healthcare: Lotivibart Shows 94% Viral Suppression in Long-Acting HIV Treatment

  Lotivibart, combined with CAB LA, maintained viral suppression in 94% of participants. Study progresses to test twice-yearly dosing. Well-tolerated with fewer adverse events in IV group.
• 

  25 February 2026

  ViiV Healthcare Unveils Data on Twice-Yearly HIV Treatments

  VH184 and VH499 show promise for twice-yearly HIV treatment, with improved resistance and tolerability, reducing the need for daily medication.
• 

  25 February 2026

  Merck Animal Health's NUMELVI: FDA-Approved JAK Inhibitor for Canine Allergic Dermatitis

  FDA approves NUMELVI for dogs 6+ months, a JAK inhibitor for allergic dermatitis, offering rapid itch relief and easy dosing. Available spring 2026.
• 

  25 February 2026

  Merck Presents Phase 3 Trial Results for HIV-1 Treatment DOR/ISL at CROI 2026

  DOR/ISL shows non-inferiority and similar safety to BIC/FTC/TAF in HIV-1 treatment-naïve adults and maintains suppression in those switching from other therapies.
• 

  25 February 2026

  MOL and Janaf Agree on Adria Pipeline Capacity Tests

  Long-term tests will assess Adria pipeline capacity. MOL seeks clarity on Russian oil shipments and criticizes Janaf's pricing. Two competitive routes are vital for regional supply security.
• 

  25 February 2026

  BASF SE Nominates Mark Garrett for Supervisory Board Election 2026

  Mark Garrett, former CEO and board member, is nominated to succeed Liming Chen on BASF's Supervisory Board, with the election set for April 2026.
• 

  25 February 2026

  QatarEnergy Awards EPC Contract for North Field West LNG Expansion

  The contract covers two LNG mega-trains, gas treatment, and CCS facilities. First LNG cargo is expected by 2031, enhancing Qatar's LNG capacity and environmental performance.
• 

  25 February 2026

  Novo Nordisk and Vivtex Collaborate on Oral Medicines for Obesity and Diabetes

  The partnership aims to develop oral biologics for obesity and diabetes, leveraging Vivtex's technology for better bioavailability and Novo Nordisk's expertise in global development and commercialization.
• 

  25 February 2026

  Technip Energies Secures Major LNG Contract for QatarEnergy's North Field West Project

  The contract involves building two LNG mega trains, boosting Qatar's LNG capacity from 77 to 142 MTPA, and capturing 2.2 MTPA of CO2 with NFS and NFW projects.
• 

  25 February 2026

  Renault's Ampere and Basquevolt Partner on Next-Gen Lithium-Metal Batteries

  The partnership aims to advance lithium metal batteries for EVs, enhancing energy density, thermal stability, and cost efficiency, while reducing manufacturing complexity and investment.
• 

  25 February 2026

  Regulation Essential for OCCS Investment in Maritime Decarbonization

  A DNV report highlights the need for clear regulations to advance OCCS technology, crucial for maritime decarbonization, with pilot projects showing technical feasibility and economic potential.
• 

  25 February 2026

  Topsoe Chosen by Petrobras for Major SAF and Renewable Diesel Project in Brazil

  Petrobras will use HydroFlex® technology to process 1 million tons of feedstock annually, pending final investment decision and approvals.
• 

  25 February 2026

  Eni Confirms Biorefining Investment in Sannazzaro de’ Burgondi

  Eni plans to convert Sannazzaro refinery units to biorefinery, boosting biofuel output without affecting traditional fuel production, aiming for 550,000 tonnes/year by 2028.
• 

  25 February 2026

  Siemens and CAPHENIA Partner to Scale Sustainable Aviation Fuel

  The partnership aims to scale SAF production using CAPHENIA's plasma technology, enhancing efficiency and enabling global rollout with Siemens' digitalization and automation solutions.
• 

  25 February 2026

  Statkraft and OX2 Partner on Finland Battery Storage Optimization

  Statkraft will optimize two large-scale battery systems in Finland, enhancing grid stability and renewable integration, starting in 2028 with a seven-year agreement.
• 

  25 February 2026

  Air Liquide Issues CHF 640 Million Multi-Tranche Bond

  The bond, under the EMTN program, has 5, 8, and 12-year tranches with an interest rate below 1%. Proceeds are for corporate use. Rated A by S&P and Scope, A2 by Moody's.
• 

  25 February 2026

  Asahi Kasei Pharma Secures Global License with Alchemedicine for Novel Compounds

  The agreement grants exclusive rights to develop preclinical compounds for autoimmune diseases, marking a deepened partnership and strategic alignment.
• 

  25 February 2026

  UBE Invests in South Korea's CheomdanLab

  CheomdanLab develops silicon nitride tech for recycling silicon waste, aiding sustainable supply chains. UBE supports their mass production and commercialization efforts.
• 

  25 February 2026

  Worley Wins EPCM Contract for Danish Hydrogen Pipeline

  Worley to provide EPCM services for Denmark's hydrogen pipeline, linking green hydrogen production with Germany, enhancing energy security and supporting the green transition.
• 

  25 February 2026

  Kemira Raises AKD Wax Prices

  Prices for AKD wax products rise 10-20% due to increased costs. Commitment to supply security and competitive production costs remains.
• 

  25 February 2026

  Clariant Gains EU Approval for Rice Bran Wax in Food-Contact Plastics

  EU approval allows rice bran wax additives in PET, PLA, and PVC for food-contact, offering a sustainable alternative to montan wax with lower carbon footprint and supply chain benefits.
• 

  25 February 2026

  Vopak Announces Record 2025 Results and EUR 1.7 Billion Shareholder Program

  Net profit rose 61% to EUR 604M. Operating cash flow hit EUR 823M. EUR 4B investment by 2030 planned. EUR 1.1B in growth projects underway. Energy transition projects worth EUR 200M in progress.